Side Effects of the New Diabetes/Weight Loss Medications

If you take a GLP-1 agonist, should you be concerned?


Recent medical literature contains multiple articles alerting physicians to adverse events identified in patients taking the blockbuster drugs liraglutide (Victoza®) and semaglutide (Ozempic®, Wygovy®, Rybelsus®) for diabetes or weight loss. The undesirable effects reported include bowel obstruction, bowel paralysis, pancreatitis and suicidal ideation. If you take one of these drugs, how concerned should you be?

To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access